Baptist Health   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Miami Florida United States (1990)

Organization Overview

First Clinical Trial
2000
NCT00004253
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Baptist Health | Baptist Health Medical Group Oncology, LLC | Baptist Health South Florida | Miami Cancer Institute at Baptist Health Inc. | Miami Cancer Institute at Baptist Health, Inc. | Miami Cancer Institute at Baptist Health of South Florida | Miami Cancer Institute (MCI) at Baptist Health, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Brain Neoplasms (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Embolism (Phase 3)

Fallopian Tube Neoplasms (Phase 2)

Fatigue (Phase 2)

Fever (Phase 2)

Glioblastoma (Phase 2)

Hematologic Diseases (Phase 2)

Hypokalemia (Phase 4)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Lung Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 2)

Neoplasms, Second Primary (Phase 1)

Pain, Postoperative (Phase 4)

Peritoneal Neoplasms (Phase 2)

Phlebitis (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Pulmonary Embolism (Phase 3)

Thromboembolism (Phase 3)

Uterine Cervical Neoplasms (Phase 2)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial APIs: 28